Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
NCT02837094
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
C19-A3 GNP
Sponsor
Cardiff University